Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Details

Connection

Nicholas Cost to Neoplasm Staging

This is a "connection" page, showing publications Nicholas Cost has written about Neoplasm Staging.

 
Connection Strength
  
 
 
2.548
  
  1. Saltzman AF, Smith DE, Gao D, Ghosh D, Amini A, Aldrink JH, Dasgupta R, Gow KW, Glick RD, Ehrlich PF, Cost NG. How many lymph nodes are enough? Assessing the adequacy of lymph node yield for staging in favorable histology wilms tumor. J Pediatr Surg. 2019 Nov; 54(11):2331-2335.
    View in: PubMed
    Score: 0.438
  2. Saltzman AF, Carrasco A, Maccini MA, Caldwell BT, Treece AL, Cost NG. Large Cystic Metanephric Adenoma in a 15-Year-Old Girl. Urology. 2017 Mar; 101:147-150.
    View in: PubMed
    Score: 0.369
  3. Walker JP, Han DS, Nicklawsky A, Boxley P, Morrison J, Tonzi M, Bruny J, Roach JP, Cost NG. Extended Lymph Node Sampling During Surgery for Pediatric Renal Tumors Concerning for Malignancy Does Not Increase Postoperative Complication Rates. J Urol. 2023 06; 209(6):1186-1193.
    View in: PubMed
    Score: 0.141
  4. Saltzman AF, Carrasco A, Amini A, Cost NG. Patterns of Care and Survival Comparison of Adult and Pediatric Wilms Tumor in the United States: A Study of the National Cancer Database. Urology. 2020 Jan; 135:50-56.
    View in: PubMed
    Score: 0.112
  5. Saltzman AF, Carrasco A, Amini A, Aldrink JH, Dasgupta R, Gow KW, Glick RD, Ehrlich PF, Cost NG. Patterns of lymph node sampling and the impact of lymph node density in favorable histology Wilms tumor: An analysis of the national cancer database. J Pediatr Urol. 2018 04; 14(2):161.e1-161.e8.
    View in: PubMed
    Score: 0.098
  6. Stokes W, Amini A, Maroni PD, Kessler ER, Stokes C, Cost CR, Greffe BS, Garrington TP, Liu AK, Cost NG. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis. J Pediatr Urol. 2017 Aug; 13(4):386.e1-386.e7.
    View in: PubMed
    Score: 0.093
  7. Rove KO, Maroni PD, Cost CR, Fairclough DL, Giannarini G, Harris AK, Schultz KA, Cost NG. Pathologic Risk Factors for Metastatic Disease in Postpubertal Patients With Clinical Stage I Testicular Stromal Tumors. Urology. 2016 11; 97:138-144.
    View in: PubMed
    Score: 0.090
  8. Rove KO, Maroni PD, Cost CR, Fairclough DL, Giannarini G, Harris AK, Schultz KA, Cost NG. Pathologic Risk Factors in Pediatric and Adolescent Patients With Clinical Stage I Testicular Stromal Tumors. J Pediatr Hematol Oncol. 2015 Nov; 37(8):e441-6.
    View in: PubMed
    Score: 0.085
  9. Cost NG, Sawicz-Birkowska K, Kajbafzadeh AM, Tourchi A, Parigi GB, Guillén G, DeFoor WR, Apoznanski W. A comparison of renal function outcomes after nephron-sparing surgery and radical nephrectomy for nonsyndromic unilateral Wilms tumor. Urology. 2014 Jun; 83(6):1388-93.
    View in: PubMed
    Score: 0.077
  10. Cost NG, Maroni P, Flaig TW. Metastatic relapse after initial clinical stage I testicular Leydig cell tumor. Oncology (Williston Park). 2014 Mar; 28(3):211, 214.
    View in: PubMed
    Score: 0.076
  11. Cost NG, Lubahn JD, Adibi M, Romman A, Wickiser JE, Raj GV, Sagalowsky AI, Margulis V. A comparison of pediatric, adolescent, and adult testicular germ cell malignancy. Pediatr Blood Cancer. 2014 Mar; 61(3):446-51.
    View in: PubMed
    Score: 0.074
  12. Cost NG, Krabbe LM, Bagrodia A, Margulis V. The use of preoperative targeted molecular therapy to allow nephron sparing for T1b tumors. Curr Opin Urol. 2013 Sep; 23(5):411-7.
    View in: PubMed
    Score: 0.073
  13. Cost NG. Testicular germ cell tumors. Current concepts and management strategies. Minerva Urol Nefrol. 2013 Jun; 65(2):133-55.
    View in: PubMed
    Score: 0.072
  14. Rakheja D, Khokhar S, Mitui M, Cost NG. Immunohistochemical expression of GLUT1 and its correlation with unfavorable histology and TP53 codon 72 polymorphism in Wilms tumors. Pediatr Dev Pathol. 2012 Jul-Aug; 15(4):286-92.
    View in: PubMed
    Score: 0.066
  15. Cost NG, Mitui M, Khokhar S, Wickiser JE, Baker LA, Rakheja D. TP53 codon 72 polymorphisms in favorable histology Wilms tumors. Pediatr Blood Cancer. 2012 Aug; 59(2):326-8.
    View in: PubMed
    Score: 0.064
  16. Cost NG, Lubahn JD, Granberg CF, Schlomer BJ, Wickiser JE, Rakheja D, Gargollo PC, Leonard D, Raj GV, Baker LA, Margulis V. Oncologic outcomes of partial versus radical nephrectomy for unilateral Wilms tumor. Pediatr Blood Cancer. 2012 Jun; 58(6):898-904.
    View in: PubMed
    Score: 0.063
  17. Cost NG, Delacroix SE, Sleeper JP, Smith PJ, Youssef RF, Chapin BF, Karam JA, Culp S, Abel EJ, Brugarolas J, Raj GV, Sagalowsky AI, Wood CG, Margulis V. The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus. Eur Urol. 2011 Jun; 59(6):912-8.
    View in: PubMed
    Score: 0.062
  18. Cost NG, Margulis V. Editorial comment. J Urol. 2011 Feb; 185(2):413; author reply 414.
    View in: PubMed
    Score: 0.061
  19. Evageliou NF, Renfro LA, Vallance KL, Varela CR, Benedetti DJ, Cost NG, Ehrlich PF, Kalapurakal JA, Khanna G, Aldrink JH, Glick RD, Ortiz MV, Parsons LN, Paulino AC, Artunduaga M, Smith EA, Dix DB, Fernandez CV, Dome JS, Geller JI, Mullen EA. Impact of post-chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children's Oncology Group AREN0532, AREN0533, and AREN03B2 studies. Cancer. 2026 Oct 01; 132(19):e70610.
    View in: PubMed
    Score: 0.045
  20. Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Gratias EJ, Cost NG, Parsons LN, Grundy PE, Fernandez CV, Geller JI, Dome JS. Concordance Between Institutional and Central Pathology, Surgery, and Radiology Reviews on the Children's Oncology Group AREN03B2 Renal Tumor Biology and Classification Study. Pediatr Blood Cancer. 2026 Oct; 73(10):e70515.
    View in: PubMed
    Score: 0.045
  21. Toumazos K, Feygin Y, Gupta N, Walker J, Cranford W, Zack J, Strup SE, Kieran K, Cost NG, Sorge C, Hensley P, McLouth C, Buchanan AF. Survivorship After Testicular Cancer in Adolescents and Young Adults: What Is Causing Death and When? J Urol. 2026 Sep; 216(3):412-419.
    View in: PubMed
    Score: 0.044
  22. Gupta N, Toumazos K, Walker J, Cranford W, Feygin Y, Zack J, Strup SE, Hensley A, Kieran K, Cost NG, Sorge C, Hensley P, McLouth C, Buchanan AF. Survivorship After Kidney Cancer in Children, Adolescents, and Young Adults-What Is Causing Death and When? Urology. 2026 May; 211:77-83.
    View in: PubMed
    Score: 0.044
  23. Ziogas IA, Corkum KS, Khomiak A, Schmoke NR, Cost NG, Bensard D, Schulick RD, Del Chiaro M, Mungo B, Roach JP. Contemporary Analysis of Solid Pseudopapillary Neoplasms in Children Versus Adults. J Surg Res. 2025 11; 315:224-230.
    View in: PubMed
    Score: 0.042
  24. Renfro LA, Vallance KL, Tfirn IC, Evageliou N, Benedetti DJ, Shamberger RC, Ehrlich PF, Cost NG, Aldrink JH, Schechter A, Treece A, Parsons LN, Walz AL, Sutton KS, Armstrong AE, Fernandez CV, Dome JS, Geller JI, Mullen EA. Associations of Patient Age, Tumor Nephrectomy Weight, and Tumor Diameter With Event-free and Overall Survival in Stage I or II Favorable Histology Wilms Tumor: A Pooled Analysis of Children's Oncology Group Studies AREN0532 and AREN03B2. Ann Surg. 2026 10 01; 284(4):759-767.
    View in: PubMed
    Score: 0.041
  25. Aldrink JH, Romao R, Ehrlich PF, Tracy E, Kieran K, Davidoff A, Glick R, Malek M, Huntington J, Saltzman AF, Cost NG, Shamberger RC. Critical elements of radical nephroureterectomy for pediatric unilateral renal tumor. Semin Pediatr Surg. 2023 Oct; 32(5):151339.
    View in: PubMed
    Score: 0.037
  26. Rodrigues Pessoa R, Morrison JC, Konety B, Gershman B, Maroni P, Kukreja JB, Cost N, Flaig T, Kessler E, Sharma P, Kim SP. National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy. Urol Oncol. 2021 12; 39(12):832.e9-832.e15.
    View in: PubMed
    Score: 0.031
  27. Halstead NV, Cost NG, Hecht SL, Walker JP. Neurofibromatosis-1 and Rhabdomyosarcoma: An Unusual Recurrence. Urology. 2020 Mar; 137:168-172.
    View in: PubMed
    Score: 0.028
  28. Sandberg JK, Mullen EA, Cajaiba MM, Smith EA, Servaes S, Perlman EJ, Geller JI, Ehrlich PF, Cost NG, Dome JS, Fernandez CV, Khanna G. Imaging of renal medullary carcinoma in children and young adults: a report from the Children's Oncology Group. Pediatr Radiol. 2017 Nov; 47(12):1615-1621.
    View in: PubMed
    Score: 0.024
  29. Geller JI, Ehrlich PF, Cost NG, Khanna G, Mullen EA, Gratias EJ, Naranjo A, Dome JS, Perlman EJ. Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2. Cancer. 2015 Jul 15; 121(14):2457-64.
    View in: PubMed
    Score: 0.020
  30. Lubahn JD, Cost NG, Kwon J, Powell JA, Yang M, Granberg CF, Wickiser JE, Rakheja D, Gargollo PC, Baker LA, Margulis V. Correlation between preoperative staging computerized tomography and pathological findings after nodal sampling in children with Wilms tumor. J Urol. 2012 Oct; 188(4 Suppl):1500-4.
    View in: PubMed
    Score: 0.017
  31. Margulis V, Master VA, Cost NG, Leibovich BC, Joniau S, Kuczyk M, Mulders PF, Kirkali Z, Wirth MP, Hirao Y, Rawal S, Chong TW, Wood CG. International consultation on urologic diseases and the European Association of Urology international consultation on locally advanced renal cell carcinoma. Eur Urol. 2011 Oct; 60(4):673-83.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)